Health ProductsType I recall Taro-Doxorubicin Liposomal: may contain particulate matter
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: Taro-Doxorubicin Liposomal
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution: National
Audience: General public, Healthcare, Hospitals
Recall class: Type I
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|
| Taro | Doxorubicin Liposomal | DIN 02493020 | Suspension | Doxorubicin Hydrochloride 2 mg/mL | HAF1937A |
Affected lot may contain the presence of particulate matter.